Collagenous colitis and lymphocytic colitis, the two main subtypes of microscopic colitis, may develop as a result of an immune response. This could happen when something causes the body to ...
A wide range of etiologies and pathogenic mechanisms underlie colitis. This Review provides an overview of the pathophysiology, epidemiology, histopathology, and clinical characteristics of ...
inhibitor in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) previously treated with a covalent BTK inhibitor. The study's primary endpoint of progression ...
The best food is home cooked. UPF enthusiasts should avoid processed foods like chips, snack foods, industrial breads and ...
Learn more about whether AbbVie Inc. or Genmab A/S is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Galapagos has also suffered other hits to key pipeline projects, including idiopathic pulmonary fibrosis (IPF) candidate ziritaxestat, two SIK inhibitors for psoriasis and ulcerative colitis ...
Janus kinase (JAK) inhibitors can quickly and effectively manage ulcerative colitis (UC), especially when more conventional treatments haven’t worked. UC is a type of inflammatory bowel disease ...
This study raises the possibility that oral low-dose methotrexate may be effective in patients with collagenous colitis and may improve the histological abnormalities in some. Side-effects appear ...
Orelabrutinib has already been approved in China as a second-line therapy for two blood cancer indications, chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell ...
The study further analyzed the patients with melanoma from seven international academic medical centers and found that 21 fatal cases were reported, of which 5 (23.8%) cases were caused by IMH, ...
Dr R Spiller, Division of Gastroenterology, C Floor, South Block, University Hospital, Nottingham NG7 2UH, UK. Email:Robin.Spiller{at}nottingham.ac.uk These guidelines were compiled by a ...